Alliance Pharma Share Price | |
---|---|
Price | 38.80 |
Bid | 38.50 |
Ask | 39.00 |
Change | -0.30 (-0.77%) |
Volume | 1,001,727 |
Open | 40.00 |
High | 40.00 |
Low | 38.00 |
Prev. Close | 39.10 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £209.68m |
Market Size | 20,000 |
52 Week High | 62.00 |
52 Week High Date | 06-Jun-2023 |
52 Week Low | 24.55 |
52 Week Low Date | 08-May-2024 |
# Trades | 153 |
---|---|
Vol. Sold | 634,910 |
Sold Value | £241.84k |
Vol. Bought | 256,911 |
Bought Value | £99.35k |
PE Ratio | 228.23529 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.358% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
31-May-24 | 16:35:03 | 38.80 | 99,364 | Sell* | 38.50 | 39.00 | 38.55k | UT Uncrossing Trade |
31-May-24 | 16:26:55 | 38.95 | 2,892 | Sell* | 38.95 | 39.20 | 1,126 | A Automatic Execution |
31-May-24 | 16:26:55 | 38.95 | 1,656 | Sell* | 38.95 | 39.20 | 645.01 | A Automatic Execution |
31-May-24 | 16:26:55 | 39.00 | 4,548 | Sell* | 39.00 | 39.25 | 1,774 | A Automatic Execution |
31-May-24 | 16:26:31 | 39.20 | 1,002 | Buy* | 39.00 | 39.20 | 392.78 | A Automatic Execution |
31-May-24 | 16:24:41 | 39.20 | 16,000 | Buy* | 39.00 | 39.20 | 6,272 | O Ordinary |
31-May-24 | 16:22:20 | 39.05 | 73 | Buy* | 38.95 | 39.05 | 28.51 | A Automatic Execution |
31-May-24 | 16:22:20 | 39.05 | 4 | Buy* | 38.95 | 39.05 | 1.56 | A Automatic Execution |
31-May-24 | 16:22:14 | 39.035 | 20,000 | Buy* | 38.95 | 39.05 | 7,807 | O Ordinary |
31-May-24 | 16:21:44 | 39.05 | 11 | Buy* | 38.95 | 39.05 | 4.30 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions